167 related articles for article (PubMed ID: 20007968)
1. CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.
Tsai AC; Pan SL; Sun HL; Wang CY; Peng CY; Wang SW; Chang YL; Kuo SC; Lee KH; Teng CM
J Biol Chem; 2010 Feb; 285(8):5497-506. PubMed ID: 20007968
[TBL] [Abstract][Full Text] [Related]
2. CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
Wang SW; Pan SL; Huang YC; Guh JH; Chiang PC; Huang DY; Kuo SC; Lee KH; Teng CM
Mol Cancer Ther; 2008 Feb; 7(2):350-60. PubMed ID: 18281518
[TBL] [Abstract][Full Text] [Related]
3. CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells.
Lee JC; Chou LC; Huang CH; Chung JG; Huang LJ; Lee KH; Hung MC; Way TD; Kuo SC
Eur J Pharmacol; 2011 Nov; 670(1):96-104. PubMed ID: 21907193
[TBL] [Abstract][Full Text] [Related]
4. Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling.
Chiang JH; Yang JS; Lu CC; Hour MJ; Chang SJ; Lee TH; Chung JG
Toxicol Appl Pharmacol; 2013 Jun; 269(2):150-62. PubMed ID: 23523585
[TBL] [Abstract][Full Text] [Related]
5. Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line.
Hsu SC; Yang JS; Kuo CL; Lo C; Lin JP; Hsia TC; Lin JJ; Lai KC; Kuo HM; Huang LJ; Kuo SC; Wood WG; Chung JG
J Orthop Res; 2009 Dec; 27(12):1637-44. PubMed ID: 19557855
[TBL] [Abstract][Full Text] [Related]
6. CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
Lin ML; Chen SS; Ng SH
Anticancer Res; 2015 Oct; 35(10):5359-68. PubMed ID: 26408697
[TBL] [Abstract][Full Text] [Related]
7. Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells.
Min KJ; Nam JO; Kwon TK
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767099
[TBL] [Abstract][Full Text] [Related]
8. The synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells.
Chou LC; Yang JS; Huang LJ; Wu HC; Lu CC; Chiang JH; Chen KT; Kuo SC; Chung JG
J Gastroenterol; 2009; 44(10):1055-63. PubMed ID: 19688288
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol induces ATM/p53-mediated death receptor and mitochondrial apoptosis in human umbilical vein endothelial cells.
Lee CF; Yang JS; Tsai FJ; Chiang NN; Lu CC; Huang YS; Chen C; Chen FA
Int J Oncol; 2016 May; 48(5):2007-14. PubMed ID: 26984266
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
12. p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4.
Xu SQ; El-Deiry WS
Biochem Biophys Res Commun; 2000 Mar; 269(1):179-90. PubMed ID: 10694497
[TBL] [Abstract][Full Text] [Related]
13. CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells.
Liu CW; Lin YC; Hung CM; Liu BL; Kuo SC; Ho CT; Way TD; Hung CH
Chem Biol Interact; 2018 Jun; 289():98-108. PubMed ID: 29679549
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.
Bagnoli M; Balladore E; Luison E; Alberti P; Raspagliesi F; Marcomini B; Canevari S; Mezzanzanica D
Mol Cancer Ther; 2007 Feb; 6(2):762-72. PubMed ID: 17308072
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
[TBL] [Abstract][Full Text] [Related]
16. Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathway.
Lee HP; Li TM; Tsao JY; Fong YC; Tang CH
Int Immunopharmacol; 2012 Jun; 13(2):163-9. PubMed ID: 22522053
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation.
Zhou J; Lu GD; Ong CS; Ong CN; Shen HM
Mol Cancer Ther; 2008 Jul; 7(7):2170-80. PubMed ID: 18645026
[TBL] [Abstract][Full Text] [Related]
18. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.
Verma RK; Gunda V; Pawar SC; Sudhakar YA
PLoS One; 2013; 8(12):e80555. PubMed ID: 24324608
[TBL] [Abstract][Full Text] [Related]
19. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
